Literature DB >> 7752873

Effects of menstrual cycle phase on athletic performance.

C M Lebrun1, D C McKenzie, J C Prior, J E Taunton.   

Abstract

The purpose of this study was to examine the effects of menstrual cycle phase on four selected indices of athletic performance: aerobic capacity, anaerobic capacity, isokinetic strength, and high intensity endurance. Sixteen eumenorrheic women (VO2max > or = 50 ml.kg-1.min-1) were tested during the early follicular (F) and midluteal (L) phases of the menstrual cycle. Cycle phases were confirmed by serum estradiol and progesterone assays. No significant differences were observed between F and L tests in weight, percent body fat, sum of skinfolds, hemoglobin concentration, hematocrit, maximum heart rate, maximum minute ventilation, maximum respiratory exchange ratio, anaerobic performance, endurance time to fatigue (at 90% of VO2max), or isokinetic strength of knee flexion and extension. Both absolute and relative VO2max, however, were slightly lower in L than in F (F = 3.19 +/- 0.09.min-1, L = 3.13 +/- 0.08.min-1, P = 0.04; and F = 53.7 +/- 0.9 ml.kg-1.min-1, L = 52.8 +/- 0.8 ml.kg-1.min-1, P = 0.06). These results suggest that the cyclic increases in endogenous female steroid hormones of an ovulatory menstrual cycle may have a slight, deleterious influence on aerobic capacity, with potential implications for individual athletes. Nevertheless, the cycle phase did not impact significantly on the majority of the other performance tests and cardiorespiratory variables measured in this study.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7752873

Source DB:  PubMed          Journal:  Med Sci Sports Exerc        ISSN: 0195-9131            Impact factor:   5.411


  54 in total

Review 1.  The physiology of the highly trained female endurance runner.

Authors:  M Burrows; S Bird
Journal:  Sports Med       Date:  2000-10       Impact factor: 11.136

2.  Do gender differences exist in the ventilatory response to progressive exercise in males and females of average fitness?

Authors:  Emma Kilbride; Paul McLoughlin; Charles G Gallagher; Helen R Harty
Journal:  Eur J Appl Physiol       Date:  2003-05-17       Impact factor: 3.078

Review 3.  Effects of the menstrual cycle on exercise performance.

Authors:  Xanne A K Janse de Jonge
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

4.  Impact of menstrual cycle phase on the exercise status of young, sedentary women.

Authors:  Leanne M Redman; Garry C Scroop; Robert J Norman
Journal:  Eur J Appl Physiol       Date:  2003-07-26       Impact factor: 3.078

Review 5.  Physiological responses to the menstrual cycle: implications for the development of heat illness in female athletes.

Authors:  Susan A Marsh; David G Jenkins
Journal:  Sports Med       Date:  2002       Impact factor: 11.136

Review 6.  Effects of estrogen replacement on metabolic factors that influence physical performance in female hypogonadism.

Authors:  W M Kohrt; R E Van Pelt; W S Gozansky
Journal:  J Endocrinol Invest       Date:  2003-09       Impact factor: 4.256

7.  Block training periodization in alpine skiing: effects of 11-day HIT on VO2max and performance.

Authors:  Fabio A Breil; Simone N Weber; Stefan Koller; Hans Hoppeler; Michael Vogt
Journal:  Eur J Appl Physiol       Date:  2010-04-04       Impact factor: 3.078

8.  Cycling time trial performance during different phases of the menstrual cycle.

Authors:  Tanja Oosthuyse; Andrew N Bosch; Susan Jackson
Journal:  Eur J Appl Physiol       Date:  2005-03-19       Impact factor: 3.078

9.  Effects of menstrual phase on performance and recovery in intense intermittent activity.

Authors:  Laura E Middleton; Howard A Wenger
Journal:  Eur J Appl Physiol       Date:  2005-10-26       Impact factor: 3.078

10.  Knee joint kinaesthesia and neuromuscular coordination during three phases of the menstrual cycle in moderately active women.

Authors:  Cecilia Fridén; Angelica Lindén Hirschberg; Tönu Saartok; Per Renström
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2005-06-08       Impact factor: 4.342

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.